Skip to main content
Category

News Archive

Holding place for old articles.

nancy-carol-squella

Maryland biotech Sequella on hunt for $20M for drug trials – Washington Business Journal

By News Archive

nancy-carol-squella

Rockville biotech Sequella inc. is looking to raise at least $20 million to advance its lead antibiotic candidate through clinical trials in drug-resistant tuberculosis and the stomach bacteria H. pylori.

If there ever was a time for the company to hit the gas pedal, it’s now. The resurgence of tuberculosis, especially in populous nations such as India and Russia, has brought what was thought of as a 19th century disease back into the spotlight. And the rise of multiple-drug-resistant strains of TB has made that fear very real in the mind of the U.S. consumer.

Read More
reg4all-logo

Genetic Alliance’s Launches Disease Registry, Reg4All, Puts Patients in Control – MIT Technology Review

By News Archive

reg4all-logo

As advances in genomics, molecular analysis, and data processing have propelled disease research forward, scientists and drug developers still face a formidable challenge: recruiting patients for their studies.

Genetic Alliance, a nonprofit that advocates for people with rare genetic disorders, is launching a new site called Reg4All that aims to entice more patients into clinical trials and disease research by giving them unprecedented privacy controls and greater say in how their data is used for research.

Read More
NewImage

Small business seminars to be offered in Montgomery County – WashingtonExaminer.com

By News Archive

NewImage

People looking to start a small business in Montgomery County can have some of their questions answered at a series of seminars focusing on small business in Germantown.

Three seminars will be held between March, April and May by Score DC, a chapter of the U.S. Service Corps and Retired Executives, and will have mentors on hand to discuss successful business practices.

Read More
nhlbi-logo-new.png

NHLBI Funding and Research Opportunities, March 13, 2013

By News Archive

nhlbi-logo-new.png

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Request for Applications (RFAs): 

  • RFA-OD-13-004: Lasker Clinical Research Scholars Program (Si2)
    This FOA solicits applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. 
  • RFA-RM-12-022: NIH Director’s Biomedical Research Workforce Innovation Award: Broadening Experiences
    The purpose of this FOA is to seek, identify and support bold and innovative approaches to broaden graduate and postdoctoral training, such that training programs reflect the range of career options that trainees (regardless of funding source) ultimately may pursue and that are required for a robust biomedical, behavioral, social and clinical research enterprise. Collaborations with non-academic partners are encouraged to ensure that experts from a broad spectrum of research and research-related careers contribute to coursework, rotations, internships or other forms of exposure. This program will establish a new paradigm for graduate and postdoctoral training; awardee institutions will work together to define needs and share best practices.
  • RFA-RM-13-001: Planning Grants for the NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (P20)
    The purpose of this Funding Opportunity Announcement (FOA) is to encourage institutions with expertise and innovative strategies for developing research and mentoring opportunities for undergraduate students from backgrounds underrepresented in biomedical research to submit applications for 6 month planning grants for the NIH Building Infrastructure Leading to Diversity (BUILD) initiative. The BUILD initiative aims to increase the diversity of the NIH-funded workforce by supporting collaborative programs that include novel approaches for enhancing undergraduate education, training, and mentorship, as well as infrastructure support and faculty development to facilitate those approaches.
  • RFA-RM-13-002: Planning Grants for the NIH National Research Mentoring Network (NRMN) (P20)
    The purpose of this Funding Opportunity Announcement (FOA) is to encourage organizations with experience in the mentorship of individuals underrepresented in the biomedical research workforce to submit planning grant applications for the NIH National Research Mentoring Network (NRMN). The NRMN will establish a nationwide consortium to provide networking and mentorship experiences for individuals from backgrounds underrepresented in biomedical research from the undergraduate to junior faculty level.

Program Announcement (PA): 

  • PAR-13-137: Bioengineering Research Grants (BRG) (R01)
    The purpose of this funding opportunity announcement is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach that can increase our understanding of and solve problems in biological, clinical or translational science.

Please note that most links to RFAs, PAs, and Guide Notices will take you to the NIH Web site. RFPs will take you to FedBizOpps. Links to RFPs will not work past their proposal receipt date. Archived versions of RFPs posted on FedBizOpps can be found on the FedBizOpps site using the FedBizOpps search function. Under “Document to Search,” select Archived Documents.

nih-nhlbi-logo

Applying for a #SBIR or #STTR grant on April 5th?

By News Archive

nih-nhlbi-logo

As our April 5, 2013 receipt date approaches and you prepare your grant submission, please remember to work to register in all the required systems (DUNS, SAM, grants.gov, eRA Commons) in advance. These must all be complete before you can submit your grant application.

Company registration at SBA’s SBIR.gov is NOT required for submissions at this time. Solicitations issued after 1/28/2013 (not due dates for solicitations already on street prior to that date) will have instructions on how to register at SBA.

Read More
commonwell-health-alliance

Q&A: McKesson and Cerner execs discuss CommonWell Health Alliance – Healthcare IT News

By News Archive

commonwell-health-alliance

After McKesson, Cerner, Allscripts, Greenway and athenahealth made news at HIMSS13 this past week with the launch of the CommonWell Health Alliance – putting aside their competitive instincts, for a moment, to pledge their common commitment to interoperability and data liquidity – Healthcare IT News spoke with McKesson CEO John Hammergren about the road ahead.

Joining Hammergren in the discussion were David McCallie, vice president, medical informatics at Cerner, and Arien Malec, vice president, data platform solutions for McKesson’s connectivity business, RelayHealth (and, in his former role at the Office of the National Coordinator for Health IT, the driving force behind the development of the Direct Project).

Read More
Bio buzz bhi jhu

BioBuzz Happy Hour – March 20, 2013 at Gaithersburg Growlers

By News Archive

Bio buzz bhi jhu

Join us on March 20 at Growlers for another BioBuzz Happy Hour

Join our sponsors, BioHealth Innovation, Inc. (BHI) and the Johns Hopkins University Center for Biotechnology Education, along with many others from our local biotech industry at another exciting BioBuzz event on March 20 from 4:30 – 7 p.m. in Gaithersburg. This month, we’re having our event a week early to accommodate BioBuzzers with kids in Montgomery County Public School system who will be on spring break the next week. We’re also holding the March BioBuzz event at a new location, Growlers in Old Towne Gaithersburg. We’re excited to see all of you soon, so please register today!

Read More
sebelius-kathleen

Welcome, @Sebelius, to the world of 140 characters – MedCity News

By News Archive

sebelius-kathleenShe sent her first tweet just after noon, and already Kathleen Sebelius (@Sebelius) has 2,000-plus followers.

The secretary of U.S. Health and Human Services is the latest federal health official to join Twitter and follows in the footsteps of colleagues Dr. Tom Frieden (@DrFriedenCDC), the director of the U.S. Centers for Disease Control and Prevention, and Dr. Francis Collins (@NIHDirector), director of the National Institutes of Health.

Read More
Johns Hopkins University

Johns Hopkins among the top schools in world reputation ranking – bmoremedia.com

By News Archive

Johns Hopkins University

Johns Hopkins University generally does well on U.S. rankings of the top colleges. 

But how does it stack up against institutions of higher learning from around the world?  Not bad. It ranks No. 19 in the Times Higher Education World Reputation Rankings of the top 100 universities from around the globe. The University of Maryland, College Park also comes up on the list, at 95.

Read More
novavax-video

VIDEO: Novavax CEO Stanley Erck Speaks to Company’s Exciting Future

By News Archive

novavax-video

Montgomery County-based Novavax is a biopharmaceutical company creating nanoparticle vaccines targeting a wide array of infectious diseases. In this new video, CEO Stanley Erck speaks about the different processes Novavax scientists are working on, and the overall momentum of the company. Mr. Erck also highlights the company’s partnerships with Path, LG Life Sciences, GE Healthcare, and Cadila Pharmaceuticals. Novavax is excited by the promising new data from clinical trials with its RSV vaccine candidate and pandemic influenza vaccine candidate, and by the potential of its technology platform. From discovery to commercialization, Novavax is positioned to develop the vaccines for tomorrow.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.